Yamamoto T, Shimano M, Inden Y, Takefuji M, Yanagisawa S, Yoshida N, Tsuji Y, Hirai M, Murohara T (2015) Alogliptin, a dipeptidyl peptidase-4 inhibitor, regulates the atrial arrhythmogenic substrate in rabbits
Optimizing healing during recovery becomes a priority
It provides indirect benefits by mediating central appetite suppression and weight loss, and finely regulates insulin secretion and sensitivity by directly acting on the islet, liver, and adipose tissue
Consult your clinician about the risks and benefits of any treatment
The gradual dose escalation helps minimize gastrointestinal side effects, which represent the most commonly reported adverse reactions